Nexelis

Nexelis, a Q² Solutions Company, Wins Best Central/Speciality Laboratory Award at the 2022 Vaccine Industry Excellence Awards

We are celebrating this week as Nexelis has been recognized at the Vaccine Industry Excellence (ViE) awards, in Washington DC.

Read More
Nexelis

Taking a biomarker-led approach to R&D

Leveraging biomarkers in the clinical field isn’t a new concept. In fact, their value has been well documented in treatments for patients and in the development of new precision medicines. However,...
Nexelis

Where the Science Leads Us: SARS-CoV-2

By March 2020, when the World Health Organization declared SARS-CoV-2 a pandemic, every major multinational pharmaceutical company, innovative biotechnology company, governmental, and nongovernmental...